Wheat germ agglutinin-grafted lipid nanoparticles: Preparation and in vitro evaluation of the association with Caco-2 monolayers

International Journal of Pharmaceutics

Volumn 397, Issue 1-2, 2010, Pages 155-163

  Liu, Ying ^a   Wang, Pengfei ^a   Sun, Chen ^a   Feng, Nianping ^a   Zhou, Wuxiong ^a   Yang, Yang ^a   Tan, Rong ^a   Chen, Zhiqiang ^a   Wu, Shan ^a   Zhao, Jihui ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Caco 2 monolayers; Lipid nanoparticles; Oral drug delivery; Wheat germ agglutinin

Indexed keywords

BUFALIN; COUMARIN; FLUORESCENT DYE; GLUTARALDEHYDE; HYDROXYL GROUP; LACTOSE; N ACETYLGLUCOSAMINE; POLYVINYL ALCOHOL; SOLID LIPID NANOPARTICLE; WHEAT GERM AGGLUTININ;

ARTICLE; CELL STRAIN CACO 2; CHEMICAL REACTION; CONFOCAL LASER MICROSCOPY; CONJUGATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HOMOGENIZATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MONOLAYER CULTURE; PARTICLE SIZE; PRIORITY JOURNAL; X RAY DIFFRACTION; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; BUFANOLIDES; CACO-2 CELLS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; POLYVINYL ALCOHOL; SURFACE PROPERTIES; WHEAT GERM AGGLUTININS;

EID: 77955983339     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.06.030     Document Type: Article

References (41)

1. ® AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J. Control. Release 2002, 83:321-330.
2. Buttini F., Soltani A., Colombo P., Marriott C., Jones S.A. Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles. Eur. J. Pharm. Sci. 2008, 33:20-28.
3. Cai Q., Zhang Z.R. Lectin-mediated cytotoxicity and specificity of 5-fluorouracil conjugated with peanut agglutinin (5-Fu-PNA) in vitro. J. Drug Target. 2005, 13:251-257.
4. Castelli F., Puglia C., Sarpietro M.G., Rizza L., Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int. J. Pharm. 2005, 304:231-238.
5. Dong Y., Feng S.S. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:6068-6076.
6. Ezpeleta I., Irache J.M., Stainmesse S., Chabenat C., Gueguen J., Orecchioni A.M. Preparation of lectin-vicilin nanoparticle conjugates using the carbodiimide coupling technique. Int. J. Pharm. 1996, 142:227-233.
7. Fischer R., Scheer H. Dissociating effect of chromophore modifications on C-Phycocyanin. J. Photochem. Photobiol. 1992, 15:91-103.
8. Gabor F., Wirth M., Jurkovich B., Haberl I., Theyer G., Walcher G., Haberl I., Theyer G., Walcher G., Hamilton G. Lectin-mediated bioadhesion: proteolytic stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes. J. Control. Release 1997, 49:27-37.
9. Gabor F., Schwarzbauer A., Wirth M. Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model. Int. J. Pharm. 2002, 237:227-239.
10. Gasco M.R. Lipid nanoparticles: perspectives and challenges. Adv. Drug Deliv. Rev. 2007, 59:377-378.
11. Gupta P.N., Mahor S., Rawat A., Khatri K., Goyal A., Vyas S.P. Lectin anchored stabilized biodegradable nanoparticles for oral immunization. 1. Development and in vitro evaluation. Int. J. Pharm. 2006, 318:163-173.
12. Han K.Q., Huang G., Gu W., Su Y.H., Huang X.Q., Ling C.Q. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World. J. Gastroenterol. 2007, 54:3374-3379.
13. Helgason T., Awad T.S., Kristbergsson K., McClements D.J., Weiss J. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J. Colloid Interface Sci. 2009, 334:75-81.
14. Hu F.Q., Yuan H., Zhang H.H., Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int. J. Pharm. 2002, 339:121-128.
15. Irache J.M., Durrer C., Duchêne D., Ponchel G. In vitro study of lectin-latex conjugates for specific bioadhesion. J. Control. Release 1994, 31:181-188.
16. Lehr C.M., Lee V.H. Binding and transport of some bioadhesive plant lectins across Caco-2 cell monolayers. Pharm. Res. 1993, 10:1796-1799.
17. Li H., Zhao X., Ma Y., Zhai G., Li L., Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 2009, 133:238-244.
18. Lim S.J., Lee M.K., Kim C.K. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J. Control. Release 2004, 100:53-61.
19. Liu Y., Chen Z.Q., Zhang X., Feng N.P., Zhao J.H., Wu S., Tan R. An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug delivery system. Chem. Pharm. Bull. 2010, 58:16-22.
20. Liu Y., Li K., Pan J., Liu B., Feng S.S. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials 2010, 31:330-338.
21. Luo Y., Chen D., Ren L., Zhao X., Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 2006, 114:53-59.
22. Masuda Y., Kawazoe N., Nakajo S., Yoshida T., Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk. Res. 1995, 19:549-556.
23. Mo Y., Lim L.Y. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate. J. Control. Release 2005, 107:30-42.
24. Montisci M.J., Giovannuci G., Duchêne D., Ponchel G. Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres. Int. J. Pharm. 2001, 215:153-161.
25. Pegi A., Julijana K., Slavko P., Janez S., Marjeta S. The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance. J. Pharm. Sci. 2003, 92:58-66.
26. Ponchel G., Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 1998, 34:191-219.
27. Pusztai A., Ewen S.W., Grant G., Brown D.S., Stewart J.C., Peumans W.J., Van Damme E.J.M., Bardocz S. Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins. Br. J. Nutr. 1993, 70:313-321.
28. Rosenblatt K.M., Bunjes H. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the α-modification. Mol. Pharm. 2009, 6:105-120.
29. Sarmento B., Martins S., Ferreira D., Souto E.B. Oral insulin delivery by means of solid lipid nanoparticles. Int. J. Nanomed. 2007, 2:743-749.
30. Schoepf U., Marecos E.M., Melder R.J., Jain R.K., Weissleder R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998, 24. pp. 642-646, 648-651.
31. 10-development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 2007, 67:141-148.
32. Teskač K., Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 2010, 390:61-69.
33. Venkateswarlu V., Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release 2004, 95:627-638.
34. Weissenböck A., Wirth M., Gabor F. WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells. J. Control. Release 2004, 99:383-392.
35. Weissleder R., Cheng H.C., Bogdanova A., Bogdanov Magnetically labeled cells can be detected by MR imaging. J. Magn. Reson. Imaging 1997, 7:258-263.
36. Wirth M., Fuchs A., Wolf M., Ertl B., Gabor F. Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharm. Res. 1998, 15:1031-1037.
37. Wirth M., Kneuer C., Lehr C.M., Gabor F. Lectin-mediated drug delivery: discrimination between cytoadhesion and cytoinvasion and evidence for lysosomal accumulation of wheat germ agglutinin in the Caco-2 model. J. Drug Target. 2002, 10:439-448.
38. Yin Y., Chen D., Qiao M., Wei X., Hu H. Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution. J. Control. Release 2007, 123:27-38.
39. Zhang W., Liu Y.L., Xu C.Y., Gao W., Bao W.F. Research on the active analgesic component of venenum bufonis. Shenyang Yao Ke Da Xue Xue Bao 1998, 15:268-271.
40. Zhang N., Ping Q., Huang G., Xu W., Cheng Y., Han X. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int. J. Pharm. 2006, 327:153-159.
41. Zhang X.X., Pan W.S., Gan L., Zhu C.L., Gan Y., Nie S.F. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem. Pharm. Bull. 2008, 56:1645-1650.